{
    "title": "Bristol Myers sales fall, cuts 2023 forecast as drugs face competition",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12344707/Bristol-Myers-sales-fall-cuts-2023-forecast-drugs-face-competition.html",
    "date": "2023-07-27",
    "keywords": [
        "year",
        "revenue",
        "cancer",
        "quarter",
        "share",
        "revlimid",
        "competition",
        "settlement",
        "blood",
        "company",
        "increase",
        "forecast",
        "analyst",
        "paragraph",
        "thursday",
        "drug",
        "pomalyst",
        "assistance",
        "foundation",
        "ceo",
        "caforio",
        "bristol",
        "eliquis",
        "reporting",
        "bln",
        "outlook",
        "cut",
        "quote",
        "lawsuit",
        "michael",
        "erman",
        "secondquarter",
        "treatment",
        "thinner",
        "face",
        "cost",
        "drugmaker",
        "drag",
        "issue",
        "product",
        "giovanni",
        "interview",
        "midst",
        "leadership",
        "change",
        "november",
        "chief",
        "officer",
        "christopher",
        "pressure",
        "launch",
        "immunotherapy",
        "pfizer",
        "canada",
        "uk",
        "range",
        "end",
        "filing",
        "patent",
        "infringement",
        "co",
        "danafarber",
        "institute",
        "boston",
        "leo",
        "bhanvi",
        "satija",
        "sonali",
        "paul",
        "mark",
        "porter",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}